Elutia Appoints Industry Veteran Guido J. Neels To Board of Directors and Audit Committee

Elutia Inc., a leader in drug-eluting biomatrix technologies, has announced the appointment of Guido J. Neels to its Board of Directors and as a member of the audit committee. Alongside this new addition, W. Matthew Zuga and Maybelle Jordan have stepped down from the company’s Board.

“Randy and I are excited to welcome Guido to our Board of Directors and the Elutia CRU,” said Kevin Rakin, Executive Chairman of Elutia. “Guido’s extensive medical technology leadership experience encompasses a broad range of managerial and strategic roles. His insights will be invaluable as we embark on building significant shareholder value, leveraging our demonstrated drug-eluting biomatrix technology, following our recent EluPro divestiture. We also thank Matt Zuga and Maybelle Jordan for their years of service and wise counsel to Elutia.”

Mr. Neels brings over 40 years of leadership and operational experience in the healthcare and medical device sectors. Currently serving as an Operating Partner at EW Healthcare Partners (EW), he has been instrumental in shaping EW’s medical device investment strategy. He also serves on the Boards of several EW portfolio and growth companies, including Bioventus, Enercon Technologies, Impulse Dynamics, and Corvista.

“I am honored to join Elutia’s Board during this pivotal moment in the Company’s strategic transformation,” said Mr. Neels. “Elutia’s pioneering technology has established that it improves patient outcomes and now has a clear path to drive its next phase of innovation into breast reconstruction. I look forward to contributing to Elutia’s exciting future and helping the company fulfill its mission.”

Previously, Mr. Neels held key leadership roles at Guidant Corporation, including Chief Operating Officer, where he oversaw four major divisions—Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions—as well as multiple corporate functions. Earlier in his career, he held sales, marketing, and management positions at Eli Lilly & Company in both the U.S. and Europe. Mr. Neels holds a Business Engineering degree from the University of Leuven (Belgium) and an MBA from Stanford University.